Learn More
Description
CaptureSelect C5 Affinity Matrix has been specifically designed for the depletion or purification of human complement component 5 from human plasma.
Features of this affinity matrix include:
- Highly selective for human complement component 5
- Complex growth media with fetal calf serum can be applied
- Non-animal derived
The high selectivity and yields obtained using CaptureSelect C5 Affinity Matrix enables a robust and efficient purification process with excellent purity obtained in one step.
Free of animal components
CaptureSelect products contain affinity ligands based on recombinant single-domain antibody fragments (VHH) created by a proprietary technology. The VHH affinity ligand is a 12 to 15 kDa fragment comprising the three complementarity-determining regions (CDRs) that form the antigen-binding domain, efficiently produced in the yeast Saccharomyces cerevisiae by a production process free of any animal components (Animal Origin-Free).
Main characteristics
- Matrix: agarose-based
- Average particle size: 65 ± 10 μm
- Ligand: CaptureSelect C5 affinity ligand
- Ligand coupling method: epoxide
- Flow characteristics: 50–200 cm/h (up to 2 bar)
- Formulation buffer: 20% (v/v) ethanol
Specifications
Specifications
| Flow Rate | 50 to 200 cm/hr. (Up to 2 bar) |
| Matrix | Agarose-based |
| Content And Storage | Store in refrigerator (2°C to 8°C). |
| Shipping Condition | Wet Ice |
| Particle Size | 65 ±10 μm |
| Form | Agarose Bead |
| Product Line | CaptureSelect |
| Quantity | 10 mL |
| Type | Affinity Matrix |
| Ligand Type | C5 affinity ligand |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.